Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

Episode 13 • October 27, 2021 • 00:50:12
Episode 13:  Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime
Few & Far Between: How Biotech Gets Built
Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

Oct 27 2021 | 00:50:12

/

Show Notes

How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.

Other Episodes

Episode 47

December 31, 2024 • 00:48:25
Episode Cover

Episode 47 - Marc Lajoie, CEO at Outpace Bio

"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at...

Listen

Episode 17

January 12, 2022 • 00:39:58
Episode Cover

Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s...

Listen

Episode 25

November 17, 2022 • 00:39:44
Episode Cover

Episode 25: Jim Geraghty, Author and Biotech Industry Veteran

“We can’t take the orphan drug revolution for granted.“ Biorasi’s Few & Far Between Podcast welcomes Jim Geraghty, author and biotech industry veteran, to...

Listen